Combination Treatment for Moderate to Severe Acne

Phase 4

Completed

• Conditions: Acne
• Interventions: Drug: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide

• Registration Number: NCT01206348
• Lead Sponsor: Medicis Global Service Corporation

Brief Summary

To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

Detailed Description

A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.

Study Timeline

• Study Start: 2010-09
• Study First Submitted: 2010-09-17
• Study First Submitted QC: 2010-09-20
• Study First Posted: 2010-09-21
• Primary Completion: 2011-07
• Study Completion: 2011-07
• Status Verified: 2011-11
• Last Update Submitted: 2011-11-28
• Last Update Posted: 2011-11-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)

Exclusion Criteria

• pregnancy and allergies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Open Label Combination	Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide	Solodyn, Ziana, Triaz FC

Primary Outcome Measures

Name	Time	Method
Proportion of patients showing improvement from Baseline and Week 12	Week 12